Skip to content

(Short) MAPS Who?

Share

Contrary to the public narrative, many Corporadelic executives agreed with Psymposia's critiques of MAPS/Lykos Therapeutics MDMA application.

Speaker: Psymposia co-founder Brian Normand on the Subliminal Jihad podcast.

Full interview: https://www.youtube.com/watch?v=I-69DgEFlVE